Azenta, Inc. 8-K

What Happened Azenta, Inc. (filed 8-K on April 2, 2026) announced that the previously disclosed sale of the entire issued share capital of B Medical Systems S.À R.L. to Thelema S.À R.L. did not close by the expected March 31, 2026 closing date. Azenta Germany GmbH (Azenta’s wholly owned subsidiary) was informed on March 27, 2026 that Thelema has not yet secured the financing required to satisfy a closing condition. The parties have not amended or terminated the Sale and Purchase Agreement; Azenta is evaluating potential paths forward while Thelema continues financing efforts.

Key Details

• Transaction: Sale of 100% of B Medical Systems S.À R.L. by Azenta Germany GmbH to Thelema S.À R.L. (definitive Sale and Purchase Agreement previously disclosed Dec 29, 2025).
• Missed deadline: The transaction did not close by the contractual March 31, 2026 date solely due to Thelema’s failure to secure required residual financing (Thelema notified Azenta on March 27, 2026).
• Current status: Agreement remains in place; closing is still subject to customary conditions, including Thelema obtaining financing. No timeline or assurance of completion has been provided.
• Company action: Azenta is evaluating options while Thelema works on financing; no amendment or termination of the agreement has been reported.

Why It Matters For investors, the delay creates uncertainty about if and when Azenta will complete the sale and realize any proceeds or strategic effects tied to B Medical Systems. The filing contains no new financial details or timing commitments, and expressly warns that the transaction’s completion depends on Thelema securing financing — there is no assurance the deal will close.